A leading University at Buffalo researcher has published a paper in The New England Journal of Medicine, which reports a major step forward in the effort to find ways to preserve the insulin-making capabilities of children and young adults newly diagnosed with Type 1 diabetes.
00:00 Impact of Diagnosis
00:24 Natural History of Type 1 Diabetes
01:06 Study on Golimumab
02:07 Can Children be Prescribed Golimumab?
02:20 A Message to Families
Explore #UBuffalo on Social Media:
ABOUT UB:
The University at Buffalo is a premier, research-intensive public university dedicated to academic excellence. Our thinking, research, creative activity and people positively impact the world. UB is New York State's flagship university and a proud member of AAU. For more info, go to buffalo.edu